Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Research and development incentive income and receivable
Research and development expenses reimbursed (as a percent)	43.50%		43.50%
Research and development incentive receivable	$ 2,071		$ 2,099
Research and development incentive income and receivable
Balance at the beginning of the period	2,099	$ 1,189	1,189
Australian research and development incentive income, net	272	$ 37	(2,051)
Cash received for eligible expenses			(1,064)
Foreign currency translation	(28)		(77)
Balance at the end of the period	2,343		2,099
Deferred Offering Costs
Deferred costs			576
Other Assets
Deposits	$ 976		1,108
Incremental borrowing rate	8.00%
License and Service
Other Assets
Deposits	$ 976		$ 1,108